FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099340048> ?p ?o ?g. }

• W2099340048 abstract "This phase I study investigates the feasibility of carboplatin plus dose-dense (q2-week) pemetrexed given concurrently with radiotherapy (XRT) for locally advanced and oligometastatic non-small cell lung cancer (NSCLC).Eligible patients had Stage III or IV (oligometastatic) NSCLC. Patients received XRT to 63 Gy in standard fractionation. Patients received concurrent carboplatin (AUC = 6) during weeks 1 and 5 of XRT, and pemetrexed during weeks 1, 3, 5, and 7 of XRT. The starting dose level (level 1) of pemetrexed was 300 mg/m2. Following the finding of dose limiting toxicity (DLT) in dose level 1, an amended dose level (level 1A) continued pemetrexed at 300 mg/m2, but with involved field radiation instead of extended nodal irradiation. Consolidation consisted of carboplatin (AUC = 6) and pemetrexed (500 mg/m2) q3 weeks × 2 -3 cycles.Eighteen patients were enrolled. Fourteen patients are evaluable for toxicity analysis. Of the initial 6 patients treated on dose level 1, two experienced DLTs (one grade 4 sepsis, one prolonged grade 3 esophagitis). There was one DLT (grade 5 pneumonitis) in the 8 patients treated on dose level 1A. In 16 patients evaluable for response (4 with oligometastatic stage IV disease and 12 with stage III disease), the median follow-up time is 17.8 months. Thirteen of 16 patients had in field local regional response. The actuarial median survival time was 28.6 months in all patients and 34.7 months (estimated) in stage III patients.Concurrent carboplatin with dose-dense (q2week) pemetrexed at 300 mg/m2 with involved field XRT is feasible and encouraging in patients with locally advanced and oligometastatic NSCLC." @default.
• W2099340048 created "2016-06-24" @default.
• W2099340048 creator A5001104767 @default.
• W2099340048 creator A5001457923 @default.
• W2099340048 creator A5026088869 @default.
• W2099340048 creator A5041522982 @default.
• W2099340048 creator A5057113388 @default.
• W2099340048 creator A5060579840 @default.
• W2099340048 creator A5061100035 @default.
• W2099340048 creator A5061548787 @default.
• W2099340048 creator A5086655595 @default.
• W2099340048 date "2011-02-16" @default.
• W2099340048 modified "2023-10-01" @default.
• W2099340048 title "Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma" @default.
• W2099340048 cites W1944220675 @default.
• W2099340048 cites W1996654617 @default.
• W2099340048 cites W2009189135 @default.
• W2099340048 cites W2030901059 @default.
• W2099340048 cites W2043225833 @default.
• W2099340048 cites W2064947884 @default.
• W2099340048 cites W2094011295 @default.
• W2099340048 cites W2099725888 @default.
• W2099340048 cites W2101760255 @default.
• W2099340048 cites W2105969273 @default.
• W2099340048 cites W2110469369 @default.
• W2099340048 cites W2118935462 @default.
• W2099340048 cites W2129559556 @default.
• W2099340048 cites W2129622436 @default.
• W2099340048 cites W2134201833 @default.
• W2099340048 cites W2134667653 @default.
• W2099340048 cites W2136240226 @default.
• W2099340048 cites W2139142789 @default.
• W2099340048 cites W2143034231 @default.
• W2099340048 cites W2162225583 @default.
• W2099340048 cites W2241814682 @default.
• W2099340048 cites W2318881995 @default.
• W2099340048 doi "https://doi.org/10.1186/1748-717x-6-17" @default.
• W2099340048 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3050732" @default.
• W2099340048 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21324160" @default.
• W2099340048 hasPublicationYear "2011" @default.
• W2099340048 type Work @default.
• W2099340048 sameAs 2099340048 @default.
• W2099340048 citedByCount "9" @default.
• W2099340048 countsByYear W20993400482012 @default.
• W2099340048 countsByYear W20993400482013 @default.
• W2099340048 countsByYear W20993400482015 @default.
• W2099340048 countsByYear W20993400482016 @default.
• W2099340048 countsByYear W20993400482021 @default.
• W2099340048 crossrefType "journal-article" @default.
• W2099340048 hasAuthorship W2099340048A5001104767 @default.
• W2099340048 hasAuthorship W2099340048A5001457923 @default.
• W2099340048 hasAuthorship W2099340048A5026088869 @default.
• W2099340048 hasAuthorship W2099340048A5041522982 @default.
• W2099340048 hasAuthorship W2099340048A5057113388 @default.
• W2099340048 hasAuthorship W2099340048A5060579840 @default.
• W2099340048 hasAuthorship W2099340048A5061100035 @default.
• W2099340048 hasAuthorship W2099340048A5061548787 @default.
• W2099340048 hasAuthorship W2099340048A5086655595 @default.
• W2099340048 hasBestOaLocation W20993400481 @default.
• W2099340048 hasConcept C126322002 @default.
• W2099340048 hasConcept C126894567 @default.
• W2099340048 hasConcept C143998085 @default.
• W2099340048 hasConcept C2776256026 @default.
• W2099340048 hasConcept C2776694085 @default.
• W2099340048 hasConcept C2777240266 @default.
• W2099340048 hasConcept C2777714996 @default.
• W2099340048 hasConcept C2778239845 @default.
• W2099340048 hasConcept C2779524853 @default.
• W2099340048 hasConcept C2781451048 @default.
• W2099340048 hasConcept C31760486 @default.
• W2099340048 hasConcept C509974204 @default.
• W2099340048 hasConcept C71924100 @default.
• W2099340048 hasConcept C90924648 @default.
• W2099340048 hasConceptScore W2099340048C126322002 @default.
• W2099340048 hasConceptScore W2099340048C126894567 @default.
• W2099340048 hasConceptScore W2099340048C143998085 @default.
• W2099340048 hasConceptScore W2099340048C2776256026 @default.
• W2099340048 hasConceptScore W2099340048C2776694085 @default.
• W2099340048 hasConceptScore W2099340048C2777240266 @default.
• W2099340048 hasConceptScore W2099340048C2777714996 @default.
• W2099340048 hasConceptScore W2099340048C2778239845 @default.
• W2099340048 hasConceptScore W2099340048C2779524853 @default.
• W2099340048 hasConceptScore W2099340048C2781451048 @default.
• W2099340048 hasConceptScore W2099340048C31760486 @default.
• W2099340048 hasConceptScore W2099340048C509974204 @default.
• W2099340048 hasConceptScore W2099340048C71924100 @default.
• W2099340048 hasConceptScore W2099340048C90924648 @default.
• W2099340048 hasIssue "1" @default.
• W2099340048 hasLocation W20993400481 @default.
• W2099340048 hasLocation W20993400482 @default.
• W2099340048 hasLocation W20993400483 @default.
• W2099340048 hasLocation W20993400484 @default.
• W2099340048 hasLocation W20993400485 @default.
• W2099340048 hasOpenAccess W2099340048 @default.
• W2099340048 hasPrimaryLocation W20993400481 @default.
• W2099340048 hasRelatedWork W1607236184 @default.
• W2099340048 hasRelatedWork W1975425037 @default.
• W2099340048 hasRelatedWork W2013653877 @default.
• W2099340048 hasRelatedWork W2037915643 @default.
• W2099340048 hasRelatedWork W2066950280 @default.

• next